Nexgel, Inc. SEC filings NXGL

Nexgel, Inc. has 327 filings in SEC EDGAR's recent list, going back to Aug 28, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

Nexgel, Inc. SEC filings
Form Description Filed Period
S-1 Registration statement Aug 20, 2026 —
424B5 Prospectus supplement Feb 10, 2026 —
424B5 Prospectus supplement Aug 1, 2025 —
424B5 Prospectus supplement Nov 13, 2024 —
424B5 Prospectus supplement Aug 13, 2024 —
424B5 Prospectus supplement Feb 21, 2024 —
S-3/A Filing May 26, 2023 —
S-3 Shelf registration Apr 13, 2022 —
424B4 Prospectus Dec 27, 2021 —
S-1MEF Filing Dec 21, 2021 —
S-1/A Amended registration statement Dec 10, 2021 —
S-1/A Amended registration statement Dec 6, 2021 —
S-1/A Amended registration statement Dec 2, 2021 —
S-1 Registration statement Nov 9, 2021 —
424B3 Prospectus May 13, 2021 —
S-1 Registration statement Apr 9, 2021 —
S-1/A Amended registration statement Apr 19, 2019 —
S-1/A Amended registration statement Mar 26, 2019 —
S-1/A Amended registration statement Mar 12, 2019 —
S-1 Registration statement Jan 9, 2019 —
S-3/A Form s-3/a Sep 8, 2014 —

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NXGL (Nasdaq), NXGLW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Langhorne, PA
SEC filer status
, Emerging growth company
SEC CIK
1468929
Former names
NEXGEL, INC. (until Oct 7, 2026); AquaMed Technologies, Inc. (until Nov 14, 2019)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.